生命科学资讯

UniQure pauses Fabry gene therapy dosing in 2 groups after toxicities emerge

Roche’s Genentech cut at least 489 jobs last year, new disclosure reveals

HHS drops legal fight over blocked 340B rebate pilot

Orphan drug tweak in US spending bill will make life easier for the FDA

White House’s online service for drug sales debuts with limited impact on prices

Illumina Enters Oversold Territory (ILMN) - Nasdaq

Money raised by biopharma

Biopharma money raised: Jan. 1-Feb. 5, 2026

BioWorld and Nasdaq stock indices

Agomab, SpyGlass cap biggest week for biotech IPOs since 2021

Biopharma money raised by month in 2026 (US$M)

Biogen CEO says Alzheimer's drug Leqembi on track for continued growth

Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study

Chutes & Ladders—Moderna CMO steps down in leadership mix-up

Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk

Medtronic hit with $382M antitrust ruling over surgical device monopoly

How Is The Market Feeling About Thermo Fisher Scientific Inc? - Benzinga

UniQure pauses higher doses in Fabry study; Aro shares Pompe data

Trump’s drug-discount website goes live

Microglia sense fungal infections through capsular components from capillary-bound Cryptococcus neoformans via endothelial nucleotide signaling